Effects of β-amyloid peptide and estrogen on platelet mitochondrial function of Sprague-Dawley rats

Platelets

Volumn 18, Issue 6, 2007, Pages 460-468

  Xu, Jie ^a,b   Shi, Chun ^a   Li, Qi ^b   Lam, Wai Ping ^b   Wai, Maria Sen Mun ^b   Yew, David T ^b  

^a SUN YAT SEN UNIVERSITY   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Amyloid peptide (A ); Adenosine triphosphate (ATP); Mitochondrial membrane potential ( m); Oestrogen; Phytoestrogen; Platelet

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMYLOID BETA PROTEIN; BIOLOGICAL MARKER; ESTRADIOL BENZOATE; GENISTEIN;

ANIMAL CELL; ARTICLE; CELL MEMBRANE POTENTIAL; CELL PROTECTION; CONTROLLED STUDY; CYTOTOXICITY; DISEASE MARKER; ESTROGEN ACTIVITY; FEMALE; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL TOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT; THROMBOCYTE ANOMALY; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION;

ADENOSINE TRIPHOSPHATE; AMYLOID BETA-PROTEIN; ANIMALS; BLOOD PLATELETS; ESTRADIOL; ESTROGENS; GENISTEIN; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; PLATELET COUNT; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 34548356758     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.1080/09537100701206808     Document Type: Article

References (58)

1. Cardoso SM, Santana I, Swerdlow RH, Oliveira CR. Mitochondria dysfunction of Alzheimer's disease cybrids enhances Abeta toxicity. J Neurochem 2004;89:1417-1426.
2. Bosetti F, Brizzi F, Barogi S, Mancuso M, Siciliano G, Tendi E.A, Murri L, Rapoport SI, Solaini G. Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer's disease. Neurobiol Aging 2002;23:371-376.
3. Watson D, Castano E, Kokjohn TA, Kuo YM, Lyubchenko Y, Pinsky Jr D, Connolly ES, Esh C, Luehrs DC, Stine WB, et al. Physicochemical characteristics of soluble oligomeric Abeta and their pathologic role in Alzheimer's disease. Neurol Res 2005;27:869-881.
4. Swerdlow RH, Kish SJ. Mitochondria in Alzheimer's disease. Int Rev Neurobiol 2002;53:341-385.
5. Cardoso SM, Santana I, Swerdlow RH, Oliveira CR. Functional mitochondria are required for amyloid β-mediated neurotoxicity. FASEB J 2001;15:1439-1441.
6. Merlo Pich M, Raule N, Catani L, Fagioli ME, Faenza I, Cocco L, Lenaz G. Increased transcription of mitochondrial genes for complex I in human platelets during ageing. FEBS Lett 2004;558:19-22.
7. Cassarino DS, Swerdlow RH, Parks JK, Parker Jr WD, Bennett Jr JP. Cyclosporin A increases resting mitochondrial membrane potential in SY5Y cells and reverses the depressed mitochondrial membrane potential of Alzheimer's disease cybrids. Biochem Biophys Res Commun 1998;248:168-173.
8. Ghosh SS, Swerdlow RH, Miller SW, Sheeman Jr B, Parker WD, Davis RE. Use of cytoplasmic hybrid cell lines for elucidating the role of mitochondrial dysfunction in Alzheimer's disease and Parkinson's disease. Ann NY Acad Sci 1999;893:176-191.
9. Khan SM, Cassarino DS, Abramova NN, Keeney PM, Borland MK, Trimmer PA, Krebs CT, Bennett JC, Parks JK, Swerdlow RH, Parker Jr WD, Bennett Jr JP. Alzheimer's disease cybrids replicate beta-amyloid abnormalities through cell death pathways. Ann Neurol 2000;48:148-155.
10. Swerdlow RH, Parks JK, Cassarino DS, Maguire DJ, Maguire RS, Bennett Jr JP, Davis RE, Parker Jr WD. Cybrids in Alzheimer's disease: A cellular model of the disease? Neurology 1997;49:918-925.
11. Sheehan JP, Swerdlow RH, Miller SW, Davis RE, Parks JK, Parker WD, Tuttle JB. Calcium homeostasis and reactive oxygen species production in cells transformed by mitochondria from individuals with sporadic Alzheimer's disease. J Neurosci 1997;17:4612-4622.
12. Trimmer PA, Swerdlow RH, Parks JK, Keeney P, Bennett Jr JP, Miller SW, Davis RE, Parker Jr WD. Abnormal mitochondrial morphology in sporadic Parkinson's and Alzheimer's disease cybrid cell lines. Exp Neurol 2000;162: 37-50.
13. Gabuzda D, Busciglio J, Chen LB, Matsudaira P, Yankner BA. Inhibition of energy metabolism alters the processing of amyloid precursor protein and induces a potentially amyloidogenic derivative. J Biol Chem 1994;269:13623-13628.
14. Allen JW, Eldadah BA, Huang X, Knoblach SM, I, Faden A. Multiple caspases are involved in beta-amyloid-induced neuronal apoptosis. J Neurosci Res 2001;65:45-53.
15. Cardoso SM, Swerdlow RH, Oliveira CR. Induction of cytochrome c-mediated apoptosis by amyloid β 25-35 requires functional mitochondria. Brain Res 2002;931:117-125.
16. Nakagawa T, Zhu H, Morishima N, Li E, Xu J, Yankner BA, Yuan J. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature 2000;403:98-103.
17. Qiao H, Koya RC, Nakagawa K, Tanaka H, Fujita H, Takimoto M, Kuzumaki N. Inhibition of Alzheimer's amyloid-beta peptide-induced reduction of mitochondrial membrane potential and neurotoxicity by gelsolin. Neurobiol Aging 2005;26:849-855.
18. Troy CM, Rabacchi SA, Friedman WJ, Frappier TF, Brown K, Shelanski ML. Caspase-2 mediates neuronal cell death induced by beta-amyloid. J Neurosci 2000;20:1386-1392.
19. Xu J, Chen S, Ku G, Ahmed SH, Xu J, Chen H, Hsu CY. Amyloid beta peptide-induced cerebral endothelial cell death involves mitochondrial dysfunction and caspase activation. J Cereb Blood Flow Metab 2001;21:702-710.
20. Nilsen J, Brinton RD. Mitochondria as therapeutic targets of estrogen action in the central nervous system. Curr Drug Targets CNS Neurol Disord 2004;3:297-313.
21. Chen JQ, Yager JD, Russo J. Regulation of mitochondrial respiratory chain structure and function by estrogens/estrogen receptors and potential physiological/pathophysiological implications. Biochim Biophys Acta 2005;1746:1-17.
22. Lobaton CD, Vay L, Hernandez-Sanmiguel E, Santodomingo J, Moreno A, Montero M, Alvarez J. Modulation of mitochondrial Ca(2+) uptake by estrogen receptor agonists and antagonists. Br J Pharmacol 2005;145:862-871.
23. Singh M, Dykens JA, Simpkins JW. Novel mechanisms for estrogen-induced neuroprotection. Exp Biol Med (Maywood) 2006;231:514-521.
24. Parkash J, Felty Q, Roy D. Estrogen exerts a spatial and temporal influence on reactive oxygen species generation that precedes calcium uptake in high-capacity mitochondria: Implications for rapid nongenomic signaling of cell growth. Biochemistry 2006;45:2872-2881.
25. Zhang Y, Bhavnani BR. Glutamate-induced apoptosis in primary cortical neurons is inhibited by equine estrogens via down-regulation of caspase-3 and prevention of mitochondrial cytochrome c release. BMC Neurosci 2005;6:13.
26. Lenaz G, Cavazzoni M, Genova ML, Aurelio MD, Merlo Pich M, Pallotti F, Formiggini G, Marchetti M, Parenti Castelli G, Bovina C. Oxidative stress, antioxidant defences and aging. BioFactors 1998;8:195-204.
27. Merlo Pich M, Bovina C, Formiggini G, Cometti GG, Ghelli A, Parenti Castelli G, Genova ML, Marchetti M, Semeraro S, Lenaz G. Inhibitor sensitivity of respiratory complex I in human platelets: A possible biomarker of ageing. FEBS Lett 1996;380:176-178.
28. Schapira AHV. Human complex I defects in neurodegenerative diseases. Biochim Biophys Acta 1998;1364:261-270.
29. Aurelio MD, Merlo Pich M, Catani L, Sgarbi GL, Bovina C, Formiggini G, Parenti Castelli G, Baum H, Tura S, Mech G. Decreased Pasteur effect in platelets of aged individuals. Ageing Dev 2001;122:823-833.
30. Edenbrandt CM, Murphy S. Adenine and guanine nucleotide metabolism during platelet storage at 22°C. Blood 1990;76: 1884-1892.
31. Peter LP, Cheryl LP, Edward LS. Apoptotic activity in stored human platelets. Transfusion 2003;43:526-535.
32. Mitchell P. Keilin's respiratory chain concept and its chemiosmotic consequences. Science 1979;206:1148-1159.
33. Azzone GF, Petronilli V, Zoratti M. 'Cross-talk' between redox- and ATP-driven H+ pumps. Biochem Soc Trans 1984;12:414-416.
34. Budd SL, Nicholls DG. Mitochondria, calcium regulation, and acute glutamate excitotoxicity in cultured cerebellar granule cells. J Neurochem 1996;67:2282-2291.
35. Boveris A, Oshino N, Chance B. The cellular production of hydrogen peroxide. Biochem J 1972;128:617-630.
36. White RJ, Reynolds IJ. Mitochondria and Na+/Ca2+ exchange buffer glutamate-induced calcium loads in cultured cortical neurons. J Neurosci 1995;15:1318-1328.
37. Nicholls DG, Budd SL. Mitochondria and neuronal survival. Physiol Rev 2000;80:315-360.
38. Huang HM, Fowler C, Xu H, Zhang H, Gibson GE. Mitochondrial function in fibroblasts with aging in culture and/or Alzheimer's disease. Neurobiol Aging 2005;26: 839-848.
39. Dykens JA, Fleck B, Ghosh S, Lewis M, Velicelebi G, Ward MW. High-throughput assessment of mitochondrial membrane potential in situ using fluorescence resonance energy transfer. Mitochondrion 2002;1:461-473.
40. Huang HM, Zhang H, Xu H, Gibson GE. Inhibition of the alpha-ketoglutarate dehydrogenase complex alters mitochondrial function and cellular calcium regulation. Biochim Biophys Acta 2003;1637:119-126.
41. Pereira C, Santos MS, Oliveira C. Mitochondrial function impairment induced by amyloid β-peptide on PC12 cells. Neuroreport 1998;9:1749-1755.
42. Pereira C, Santos MS, Oliveira C. Involvement of oxidative stress on the impairment of energy metabolism induced by A beta peptides on PC12 cells: Protection by antioxidants. Neurobiol Dis 1999;6:209-219.
43. Boyd-Kimball D, Poon HF, Lynn BC, Cai J, Pierce Jr WM, Klein JB, Ferguson J, Link CD, Butterfield DA. Proteomic identification of proteins specifically oxidized in Caenorhabditis elegans expressing human Aβ(1-42): Implications for Alzheimer's disease. Neurobiol Aging 2006;27:1239-1249.
44. Arias C, Montiel T, Quir oz-Baez R, Massieu L. Beta-Amyloid neurotoxicity is exacerbated during glycolysis inhibition and mitochondrial impairment in the rat hippocampus in vivo and in isolated nerve terminals: Implications for Alzheimer's disease. Exp Neurol 2002; 176:163-174.
45. Simakova O, Arispe NJ. Early and late cytotoxic effects of external application of the Alzheimer's Abeta result from the initial formation and function of Aβ ion channels. Biochemistry 2006;45:5907-5915.
46. Smith JD, Levin-Allerhand JA. Potential use of estrogen-like drugs for the prevention of Alzheimer's disease. J Mol Neurosci 2003;20:277-281.
47. Vegeto E, Belcredito S, Ghisletti S, Meda C, Etteri S, Maggi A. The endogenous estrogen status regulates microglia reactivity in animal models of neuroinflammation. Endocrinology 2006;147:2263-2272.
48. Hiltunen M, Iivonen S, Soininen H. Aromatase enzyme and Alzheimer's disease. Minerva Endocrinol 2006; 31:61-73.
49. Goodenough S, Schafer M, Behl C. Estrogen-induced cell signalling in a cellular model of Alzheimer's disease. J Steroid Biochem Mol Biol 2003;84:301-305.
50. Bang OY, Hong HS, Kim DH, Kim H, Boo JH, Huh K, Mook-Jung I. Neuroprotective effect of genistein against beta amyloid-induced neurotoxicity. Neurobiol Dis 2004;16: 21-28.
51. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M, Fukami Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 1987;262: 5592-5595.
52. Gutierrez-Zepeda A, Santell R, Wu Z, Brown M, Wu Y, Khan I, Link CD, Zhao B, Luo Y. Neuroprotective effect of genistein against beta amyloid-induced neurotoxicity. Neurobiol Dis 2004;16:21-28.
53. Heikkinen T, Kalesnykas G, Rissanen A, Tapiola T, Iivonen S, Wang J, Chaudhuri J, Tanila H, Miettinen R, Puolivali J. Estrogen treatment improves spatial learning in APP + PS1 mice but does not affect beta amyloid accumulation and plaque formation. Exp Neurol 2004;187:105-117.
54. Henderson VW, Paganini-Hill A, Miller BL, Elble RJ, Reyes PF, Shoupe D, McCleary CA, Klein RA, Hake AM, Farlow MR. Estrogen for Alzheimer's disease in women: Randomized, double-blind, placebo-controlled trial. Neurology 2000;54:295-301.
55. Mulnard RA, Cotman CW, Kawas C, van Dyck CH, Sano M, Doody R, Koss E, Pfeiffer E, Jin S, Amst AG. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: A randomized controlled trial. Alzheimer's Disease Cooperative Study. JAMA 2000;283:1007-1015.
56. Thal LJ, Thomas RG, Mulnard R, Sano M, Grundman M, Schneider L. Estrogen levels do not correlate with improvement in cognition. Arch. Neurol 2003;60:209-212.
57. Wang PN, Liao SQ, Liu RS, Liu CY, Chao HT, Lu SR, Yu HY, Wang SJ, Liu HC. Effects of estrogen on cognition, mood, and cerebral blood flow in AD: A controlled study. Neurology 2000;54:2061-2066.
58. Vincent B, Smith JD. Effect of estradiol on neuronal Swedish-mutated beta-amyloid precursor protein metabolism: Reversal by astrocytic cells. Biochem Biophys Res Commun 2000;271:82-85.